A phase I trial of ISIS 426115 (ISIS GCCRRx) in volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Jun 2013
At a glance
- Drugs IONIS GCCRrx (Primary) ; Dexamethasone
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 18 Jun 2013 Results presented at the 95th Annual Meeting of the Endocrine Society.
- 07 Dec 2012 Positive results were reported in an Isis Pharmaceuticals media release.
- 07 Dec 2012 Status changed from recruiting to completed.